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ABSTRACT
This article reports on the outcomes associated with remote physiological monitoring (RPM)
conducted as part of a heart failure disease management program. Claims data, medical
records, data transmission records, and survey results for 91 individuals ages 50–92 (mean 74
years) successfully completing a heart failure RPM program were analyzed for time periods
before, during, and after the monitoring intervention. The program was associated with sig-
nificant reductions in per member per month costs and emergency room and hospital uti-
lization. More detailed analyses were performed for specific gender and age subgroups. Par-
ticipant surveys indicated high levels of satisfaction, and improvements in self-perceived
health status, self-efficacy, and self-management behaviors. This study is the first to assess
the impact of a RPM program following removal of the monitoring equipment. The results
indicate that RPM, as a component of a traditional disease management program, has a sus-
tained, beneficial effect on participants’ lifestyles after the monitoring period has ended. (Dis-
ease Management 2005;8:379–381)
INTRODUCTION
IN THE PAST 30 YEARS, the prevalence of heartfailure (HF) in the United States has grown
by 500%.1 As the elderly population continues
to expand, and as persons with HF live longer,
the potential cost and burden to society is enor-
mous.1
HF is one of the most fatal and costly chronic
diseases affecting the elderly. With greater than
700,000 hospitalizations for Medicare beneficia-
ries each year, it accounts for more admissions
than any other elderly diagnosis.2 Readmissions
also are prevalent among those with HF, with
78% of patients having at least two hospital ad-
missions per year.3 Fifty percent of HF patients
have three or more comorbidities,3 and these pa-
tients take an average of six medications at any
given time.4 Costs of HF are high, with an av-
erage of $7863 per hospitalization,5 an average
of $438 per month for HF medications,6 and to-
tal annual direct and indirect costs to the U.S.
healthcare system of $27.9 billion.7
These high cost and utilization figures can be
1American Healthways, Nashville, Tennessee.
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attributed in part to gaps in quality of care for
HF patients. For instance, despite evidence
showing that beta-blockers and angiotensin-
converting enzyme inhibitors (ACE-I) can sig-
nificantly decrease morbidity and mortality 
of congestive heart failure (CHF) patients, the
rates of prescription are low, 18% and 38% 
(for beta-blockers and ACE-I, respectively).5
A study of academic medical centers found 
that opportunities for improvement existed in 
ACE-I dosing as well as in patient education
regarding the importance of monitoring daily
weights, and in smoking cessation.8
An estimated 20% of hospitalizations for HF
(representing $2.72 billion in total costs) could
be prevented through improvements in med-
ical management and patient self-management
(ie, lifestyle changes and adherence to medica-
tions).8 The disease management (DM) indus-
try has identified opportunities for improve-
ment in quality of care and outcomes for HF.
Industry initiatives target both providers and
patients, with the dual goals of improving clin-
ical outcomes while decreasing avoidable uti-
lization. Numerous studies of HF DM programs
have demonstrated improvements including
decreased hospitalizations, improved prescrib-
ing patterns (improved use and dose of beta-
blockers and ACE-I), decreased costs, and
shorter lengths of stay.9–11
Certain HF DM programs have enhanced
their interventions by incorporating remote
physiological monitoring (RPM). Studies citing
use of remote monitoring yield ambiguous re-
sults; some have reported improved outcomes
such as reduced mortality, decreased utiliza-
tion, and lower hospital charges,12–14 while oth-
ers have found no differences when the RPM
component is taken into account.14
The purpose of this study was to examine the
effect of RPM in a HF DM population during
and after the monitoring period. While previ-
ous studies have examined the effect of remote
monitoring on outcomes, as noted above, none
have captured the impact of such a program on
the utilization and health status of HF patients
after the monitoring phase had concluded. This
study evaluates the initial impact and the long-
term effects of RPM in a HF population by ex-
amining data both during and after “gradua-
tion” from such a program.
METHODS
Program description
Participants in this study are a subset of
members enrolled in a standard HF DM pro-
gram. For inclusion in the standard program,
health plan members are identified via a spe-
cific algorithm using HF ICD-9 diagnosis
codes. Identified members and their primary
care physicians receive letters explaining the
details and goals of the program, emphasizing
that the program supports the physician’s plan
of care for his or her health plan members with
HF. Standard HF program members routinely
receive written materials describing the stan-
dards of care for HF as well as regular calls
from a registered nurse (RN). Common inter-
ventions by the RN during the care calls in-
clude teaching the participant to: assess for
signs and symptoms of worsening HF, self-
monitor for potential exacerbations, and use
physician-directed strategies to prevent exac-
erbations. Evidence-based HF medications,
blood pressure (BP) control, and appropriate
nutritional therapy are reviewed. Members
also are assisted in developing a goal and de-
termining the appropriate actions to take for
optimal management of their illness, for exam-
ple: eating a low sodium diet, routinely taking
and monitoring blood pressure, and monitor-
ing weight on a daily basis.
When claims data indicate instability of a
participant’s HF, he or she is considered for
placement in the RPM program. Selection for
the RPM program is made on the basis of meet-
ing one of the following criteria: two HF-re-
lated hospitalizations in the past 12 months,
two HF-related emergency department visits in
the past 12 months, or one of each of the afore-
mentioned within a 12-month period. Clini-
cians may refer members to the RPM program,
particularly those who are not monitoring their
symptoms daily or are displaying other signs
of non-adherence to optimal self-management
(eg, lack of willingness to follow restricted so-
dium in diet or lack of compliance to medica-
tion regimen).
Participants in the RPM program receive a
scale, a BP machine, and an electronic “hub”
for transmitting weight and BP data via their
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home telephone lines to clinicians in a Care En-
hancement Center (CEC). These clinical data,
transmitted by the participant on a daily basis,
are uploaded into an electronic medical record
and compared with previous values. If the data
violate predetermined alert parameters, the
system prompts CEC clinicians to call the par-
ticipant and discuss current signs and symp-
toms. In this way, the clinicians guide partici-
pants in taking actions to better control the
symptoms of their HF.
Graduation from the RPM program occurs
when the participants are: following a low so-
dium diet, weighing daily, demonstrating an
ability to correctly verbalize what they need to
do if symptoms change or worsen, and main-
taining stable vital signs. When remote moni-
toring is discontinued, the participant receives
a graduation packet containing instructions, a
home monitoring log, and a coupon for a bat-
tery-operated scale.
Over the past three years, 4,103 members with
HF have participated in the standard HF DM
program. Of these, 852 have participated in the
RPM program. This study sample consisted of
the first 93 “graduates” of the RPM program 
who were followed subsequently for 6 months
while enrolled in the standard HF DM program.
RPM has intrinsic value as a tool for early
identification of worsening physiological pro-
files, enabling clinicians to take corrective mea-
sures before patients require emergency care or
hospitalization. In the context of this program,
the ultimate goal of RPM is to initiate and sus-
tain positive self-care behavior change among
individuals with HF. By undergoing daily self-
monitoring of weight and blood pressure, in-
dividuals become aware of behaviors that con-
tribute to fluctuations in weight and blood
pressure. Once these behaviors are identified,
individuals learn to restrict or monitor them to
prevent further “alarm” situations from occur-
ring. Previous literature has shown that men
and women differ in their malleability to be-
havior change initiatives.15–17 Accordingly, this
study seeks to delineate whether, and to what
extent, various gender and age subgroups may
be more or less responsive to these types of
techniques so that intensive resources such as
remote monitoring can be applied most effi-
ciently and effectively.
Sample description
Subjects were identified through analysis of
database records of graduation from the RPM
program. Only those participants who gradu-
ated were included in this study, to ensure the
availability of data for the baseline, monitoring,
and 6-month follow-up periods. A total of 93
members graduated from the remote monitor-
ing program; after two exclusions (described
below), 91 were included in the study. Data
were obtained from four sources: medical
claims, electronic medical records from the DM
clinical information system, home monitoring
equipment data transmissions, and a telephone
survey.
Age and gender. A total of 93 male and female
subjects, ages 50–92 (at graduation), were ini-
tially enrolled in this study. Two participants,
one male and one female, were excluded on the
basis of clinical criteria (claims with ICD-9 di-
agnoses unrelated to HF which resulted in fi-
nancial per member per month (PMPM) costs
more than four standard deviations from the
mean for this group.) Forty-seven percent of
the sample was female (n  43), and 53% was
male (n  48). The mean age was 74. Average
female age was 76 years, while average male
age was 73 years. Individuals were classified
into one of three age groups for analysis: 50–64,
65–79, or 80–92.
A comparison of the graduates (n  91) stud-
ied with the remainder of the population (n 
736) shows no difference by gender (chi-
square  0.87, df  1, p  n.s.) or age group
(chi-square  7.735, df  3, p  n.s.). However,
the difference by age group approaches statis-
tical significance (7.735 vs. a critical value of
7.815); for example, while 27.4% of those not
included in the study sample were under age
65, only 15.4% of sample members were under
65. Thus, some caution should be used in gen-
eralizing the results by age group.
Burden of illness. It is well established in the
health care research literature that males and fe-
males have different utilization patterns. Addi-
tionally, individuals with greater illness burdens
tend toward heavier healthcare utilization. Be-
cause of the small sample size and the slight
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imbalance in the gender distribution, the au-
thors sought to assess potential differences in
illness burden between males and females
prior to the intervention phase to determine the
potential impact of this imbalance on study
findings. To examine gender differences in pre-
intervention morbidity levels, adjusted clinical
groups (ACGs) were calculated based on the
claims data for the year prior to the interven-
tion phase to obtain the relative weights for
each group. The relationship between gender
and mean relative weight (case-mix index) was
assessed through a one-way analysis of vari-
ance (ANOVA). The result of the ANOVA was
a nonsignificant F value (F  1.06), suggesting
that the males and females in the study were
not substantially different in terms of illness
burden prior to the intervention phase of the
study.
Data collection
As noted above, data were collected from
four sources: insurance claims, DM program
electronic medical records, RPM data trans-
mission records, and a post-graduation survey.
Insurance claims data. Inpatient, outpatient,
and pharmacy claims were examined for RPM
program participants. The claims were sorted
by date and aggregated to generate totals for
the pre-monitoring, monitoring, and post-mon-
itoring periods. Because length of coverage by
the insurer varied among participants, the
“pre-RPM” claim period was standardized by
limiting it to the 12 months prior to the RPM
start date. All claims from the RPM start date
through the RPM graduation date were classi-
fied as “during the RPM claim period”; for
eight study participants, monitoring lasted for
only 8–11 months; for all other study partici-
pants, monitoring lasted 12 months or longer,
but only the first 12 months of data were ana-
lyzed. All claims dated after the participant’s
RPM graduation were classified as “post-RPM
claim period”; the average time off of remote
monitoring was 5.8 months.
The cost metric, calculated for each of the
three time periods, was average PMPM costs.
The three utilization metrics, calculated for
each of the three time periods, included emer-
gency room (ER) visits per thousand member-
years, hospital admissions per thousand mem-
ber-years, and hospital readmissions (within 
60 days post discharge) per thousand member-
years. Student t-tests were performed to deter-
mine the statistical significance of comparisons
of PMPM costs between the pre-RPM and RPM
claim periods and between the pre-RPM and
post-RPM periods. Chi-square tests for equiv-
alence of person-time rates were performed to
evaluate the statistical significance of changes
in all three measures of utilization between the
pre-RPM and post-RPM periods. Metrics were
calculated and analyses were conducted for the
entire group for all three time periods. Then, ad-
ditional subgroup analyses examined changes
in the three measures of utilization for the six
gender-age subgroups.
DM program medical records. Clinical data, de-
mographic data (age and gender), and program
data (monitoring start date and graduation
date) were retrieved from participants’ elec-
tronic medical records, which nurses used to
record interactions with participants.
RPM data transmission records. The RPM
equipment provides electronic transmission of
weight, BP, and pulse readings to the nurse call
center on a daily basis. Parameters are set to
define the “safe” range and, when readings oc-
cur outside of this range, alerts are triggered.
Monitoring alert data were extracted from the
electronic clinical information system and ex-
amined by type of alert (ie, change in systolic
BP, change in diastolic BP, or change in
weight). The proportion of participants having
no alerts during their first month of home mon-
itoring was compared with the proportion hav-
ing no alerts during the last month of moni-
toring, for all three types of alerts. The
statistical significance of these changes over
time was evaluated using chi-square tests.
Survey data. A postgraduation survey was
developed to assess the impact of the RPM pro-
gram on the participants’ perceived health sta-
tus and health behavioral habits. The questions,
developed in conjunction with a cardiologist
and other cardiac and RPM clinical experts,
were designed to assess such constructs as per-
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ceived severity of current condition, whether
or not the member had access to a method for
daily weighing, whether or not the member con-
tinued to engage in daily weighing after gradu-
ation, perception of “empowerment,” use of di-
uretic (or change in use), whether or not the
member had an action plan, current symptom
evaluation, whether or not the member engaged
in smoking cessation, and whether the imple-
mentation of other behavioral health improve-
ments had taken place during the home moni-
toring period. The survey was content validated
and administered telephonically by a CEC nurse
approximately three months after participants’
graduation from the RPM program.
RESULTS
PMPM
The 91 participants experienced a significant
(p  0.04) reduction in PMPM costs during the
8 to 12-month period on home monitoring (av-
erage $629.79) when compared to PMPM costs
in the pre-RPM period (average $1,002.81;
Table 1). Participant claims from the post-mon-
itoring period revealed a further decrease in
PMPM costs (average $508.54; p  0.02) when
compared to the pre-RPM period.
Utilization
As shown in Table 2, cost savings were de-
rived from decreased rates of emergency vis-
its, hospital admissions, and readmissions dur-
ing remote monitoring and after removal of the
monitor. Emergency visits per thousand mem-
ber-years dropped from 1013.8 pre-RPM to
633.1 during RPM and to 573.6 post-RPM; the
pre- to post-monitoring reduction was signifi-
cant (p  0.01). Admissions per thousand
member-years dropped from 705.2 pre-RPM to
429.4 during RPM and to 321.2 post-RPM (pre-
to post-monitoring decrease significance: p 
0.01). And, readmissions for HF within 60 days
also decreased, from 143.3 per thousand mem-
ber-years pre-RPM to 72.8 during monitoring
and to 22.9 post-RPM (pre- to post-monitoring
decrease significance: p  0.04).
Examining utilization trends by gender and
age group, emergency visits per thousand
member-years showed decreases between the
pre-RPM and the post-RPM period in five out
of six comparisons (Table 3). However, the de-
crease was statistically significant only for the
youngest males (ages 50–64, p  0.034). The
only group where there was an apparent (but
nonsignificant) rise in emergency visits was fe-
males ages 65–79.
Overall, hospital admissions per thousand
member-years showed decreases from the pre-
RPM period to the post-RPM period for five out
of six comparisons by gender and age group
(Table 4). As with emergency visits, the decrease
reached statistical significance only for males
ages 65–79 (p  0.031). The only exception to the
downward trend in admissions was the rise in
admissions among females ages 65–79, also
matching the pattern for emergency visits.
Turning to readmissions within 60 days,
while there were no statistically significant dif-
ferences, the pattern was the same as for emer-
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TABLE 1. PER MEMBER PER MONTH (PMPM) COSTS, FOR PRE-MONITORING, 
MONITORING, AND POST-MONITORING PERIODS, BY GENDER
Pre-RPM During-RPM Post-RPM
mean mean mean
PMPM N (SD) (SD) Pre to during (SD) Pre to post
Males 48 $947.92 $675.86 t  1.36 $485.42 t  1.76
($1849.5) ($782.5) df  47 ($577.2) df  47
p  0.18 p  0.08
Females 43 $1,064.45 $579.81 t  1.62 $535.17 t  1.51
($2232.2) ($691.1) df  42 ($1225.5) df  42
p  0.11 p  0.14
Overall 91 $1,002.81 $629.79 t  2.12 $508.54 t  2.31
($2028.6) ($736.7) df  90 ($935.9) df  90
p  0.04 p  0.02
gency visits and admissions (Table 5). Five out
of six gender-age group cohort comparisons
showed either a reduction in the readmission
rate or persistence at no readmissions; the only
exception, as for the other types of utilization,
was that females ages 65–79 experienced a
small (nonsignificant) increase in readmissions.
Volume of alerts
The number of participants with no alerts for
systolic or diastolic BP increased sharply from
the first to the last month of RPM (p  0.0001
for systolic BP; p  0.003 for diastolic BP). On
the other hand, the number of participants with
no weight alerts decreased: 10 fewer partici-
pants had no weight alerts in the last month
than in the first month of RPM; however, this
trend did not reach statistical significance
(Table 6).
Survey findings
Results of the telephonic survey showed that
most participants were satisfied with the RPM
program. In fact, in response to an open-ended
question, many expressed a preference for be-
ing in a monitoring program. Self-perceived
health status improved while participants were
in the program, with 97% of participants re-
porting that their health improved or stayed
the same after graduating from RPM. Self-effi-
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TABLE 2. UTILIZATION OF EMERGENCY VISITS PER 1000 MEMBER-YEARS, ADMISSIONS PER 1000 MEMBER-YEARS, AND
READMISSIONS (WITHIN 60 DAYS) PER 1000 MEMBER-YEARS, FOR PRE-MONITORING AND POST-MONITORING PERIODS
Utilization Pre-RPM During-RPM Post-RPM Pre to post
Emergency visits/1000 member-years 1013.8 633.1 573.6 X2  6.55, df  1, p  0.01
Admissions/1000 member-years 705.2 429.4 321.2 X2  7.48, df  1, p  0.01
Readmissions/1000 member-years 143.3 72.8 22.9 X2  4.09, df  1, p  0.04
TABLE 3. EMERGENCY VISITS PER 1000 MEMBER-YEARS, FOR PRE-MONITORING, MONITORING, 
AND POST-MONITORING PERIODS, BY GENDER AND AGE GROUP
ED visits per
1000 member-years N Pre During Post Pre to post
Males
50–64 9 1000.0 779.2 0.0 X2  4.50
df  1
p  0.034
65–79 25 840.0 583.3 328.8 X2  3.18
df  1
p  0.075
80–92 14 1142.9 617.6 900.0 X2  0.25
df  1
p  0.617
Females
50–64 5 1400.0 766.0 0.0 X2  2.68
df  1
p  0.102
65–79 19 480.0 388.2 560.7 X2  0.08
df  1
p  0.777
80–92 19 1578.9 840.3 1061.9 X2  1.20
df  1
p  0.273
cacy also showed improvement, with 97% of
participants reporting that being in the pro-
gram made them better able to take care of
themselves. Eighty-one percent of participants
specifically reported making positive dietary
changes as a result of the program, and 100%
of participants reported having an appropriate
action plan should a change in weight occur.
DISCUSSION
Overall PMPM costs decreased significantly
between the pre-RPM period, and both the
monitoring period and the post-RPM period.
The decrease was not statistically significant for
either males or females, considered separately,
given the small cohort sizes. Nevertheless, each
gender experienced the same rate of reduction
in costs, approximately 50%.
These cost reductions resulted from signifi-
cant reductions in each type of utilization stud-
ied: emergency visits, inpatient admissions,
and readmissions within 60 days. The rates of
decrease for these three dimensions of utiliza-
tion ranged from a 43% reduction in the emer-
gency visit rate to a 54% reduction in the ad-
mission rate to an 84% reduction in the read-
mission rate.
The findings from this study were consistent
with findings from comparable studies. In a
randomized controlled trial (RCT) of HF pa-
tients researchers found that health outcomes
and mortality were improved in the RPM
group without an increase in utilization.12 Sim-
ilarly in the study presented, the improvement
in health status was not associated with an in-
crease in utilization—rather utilization de-
creased during the monitoring period and af-
ter graduation.
Bondmass et al13 demonstrated clinical and
cost-effectiveness of telemonitoring for HF pa-
tients, noting a significant (p  0.001) decrease
in readmissions, length of stay, and hospital
charges as well as an increase in quality of life
(p  0.002). In the present study, readmissions
also decreased significantly during and after
the RPM intervention and quality of life im-
proved with increased self-efficacy.
Considerable research has demonstrated
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TABLE 4. ADMISSIONS PER 1000 MEMBER-YEARS, FOR PRE-MONITORING, MONITORING, 
AND POST-MONITORING PERIODS, BY GENDER AND AGE GROUP
Admissions
per 1000
member-years N Pre During Post Pre to post
Males
50–64 9 777.8 467.5 444.4 X2  0.50
df  1
p  0.480
65–79 25 560.0 361.1 82.2 X2  4.63
df  1
p  0.031
80–92 14 714.3 397.1 600.0 X2  0.09
df  1
p  0.764
Females
50–64 5 1800.0 510.6 0.0 X2  3.45
df  1
p  0.063
65–79 19 320.0 388.2 448.6 X2  0.28
df  1
p  0.597
80–92 19 947.4 537.8 318.6 X2  3.37
df  1
p  0.066
gender differences in the diagnosis, manage-
ment, and outcome of HF15,16,18,19; accordingly,
the authors anticipated finding gender differ-
ences in the effects of RPM on both cost and
utilization in this study. However, the exami-
nation of declines in utilization by gender and
age group showed fairly uniform patterns:
there were sharp but generally nonsignificant
decreases for each gender-age cohort except for
females ages 65–79, who had small, nonsignif-
icant increases. While the small cohort sizes
preclude making generalizations with much
confidence, it is the overall consistency of the
findings across the gender and age compar-
isons, rather than any variations, that are most
notable.
There were inconsistent findings regarding
alerts: while the number of participants with
no alerts for systolic or diastolic BP increased
significantly from the first to the last month of
RPM, there was actually a decrease, albeit non-
significant, in the number of participants with-
out weight alerts. The two strong BP alert find-
ings suggest that the RPM program promotes
behavior change regarding BP control. If this is
the case, significant reductions in the number
of alerts to the CEC may not only improve clin-
ician workflow by reducing avoidable phone
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TABLE 5. READMISSIONS (WITHIN 60 DAYS) PER 1000 MEMBER-YEARS, FOR PRE-MONITORING, 
MONITORING, AND POST-MONITORING PERIODS, BY GENDER AND AGE GROUP
Readmissions
per 1000
member-years N Pre During Post Pre to post
Males
50–64 9 111.1 233.8 0.0 X2  0.50
df  1
p  0.480
65–79 25 80.0 55.6 0.0 X2  0.97
df  1
p  0.325
80–92 14 0.0 44.1 0.0 NA
Females
50–64 5 1000.0 127.7 0.0 X2  1.92
df  1
p  0.166
65–79 19 53.3 0.0 112.1 X2  0.29
df  1
p  0.590
80–92 19 210.5 100.8 0.0 X2  1.98
df  1
p  0.159
TABLE 6. ALERTS FOR WEIGHT, SYSTOLIC BLOOD PRESSURE (BP), AND DIASTOLIC
BLOOD PRESSURE FOR FIRST AND LAST MONTHS OF MONITORING
First month of Last month
Percentage without alerts RPM of RPM N X2, df, p
No systolic BP alerts 35 86 91 61.51, 1,  0.0001
No diastolic BP alerts 73 87 91 8.76, 1, 0.003
No weight alerts 51 41 91 2.15, 1, 0.142
RPM, remote physiological monitoring.
calls, but also may allow clinicians to devote
more time to participants who are most in need
of telephonic interventions.
The reductions in utilization and the subse-
quent cost savings described are most likely the
result of positive changes in member behavior,
such as daily weight monitoring, adhering to a
low salt diet, identifying symptoms of HF and
when to call the doctor, and checking BP. In
general, members continued these activities af-
ter the RPM equipment was removed, indicat-
ing that a RPM program may create sustained
behavior change among persons with HF.
Study limitations and implications for 
future study
Study limitations include issues of sample
size, length of follow-up, lack of randomized
control and “regression to the mean,” a prob-
lem inherent in all pre-post studies of DM in-
terventions.
The small sample size reduced the power to
identify statistically significant decreases in costs
and utilization. The gender-age subgroups were
especially small, reducing opportunities for gen-
eralizing from those specific results. Analyses
from a planned Phase II RPM study, with larger
samples of RPM program graduates, will pro-
vide greater statistical power and age-gender co-
horts of sufficient size to identify differential ef-
fects for males and females, for different age
groups, and age-gender interactions.
In the present study, the length of time avail-
able for follow-up data collection following
home monitoring was truncated at six months,
with the average time off of remote monitoring
being 5.8 months. The Phase II RPM study will
evaluate utilization, PMPM costs, and behav-
ior change practices more longitudinally.
The present study lacked randomization and
a control group. The Phase II Study will be a
randomized, controlled study with matched
samples randomly assigned either to the Basic
HF DM Program or the Basic HF DM Program
plus RPM.
Finally, and perhaps most importantly, there
are the questions of whether, and to what de-
gree, the observed decreases in utilization and
cost result from regression to the mean, ie, a
process where members are targeted for the
DM program and RPM based on exacerbations
of HF, and their conditions moderate during
the study period for reasons unrelated to DM
in general and RPM monitoring in particular.
Although no extraordinary measures were
taken to control for this phenomenon, an anal-
ysis of pre-intervention utilization revealed no
extremely high-cost patients in the sample. The
Phase II study design will seek to control for
regression to the mean thus minimizing po-
tential for overstatement of the effect of RPM
on utilization and cost. Additional planned im-
provements to the Phase II RPM study include:
use of “smart” (interactive) patient monitors,
development and application of criteria for re-
moving monitors, and studying patient atti-
tudes and attributes that contribute to the suc-
cess or failure of RPM as a tool for positive
health behavior change.
CONCLUSION
This study is the first to examine the impact of
a Remote Physiological Monitoring program af-
ter the monitoring period has been completed.
With remote monitoring, most members experi-
enced reduced utilization, decreased PMPM
costs, and improved self-perceived health status,
self-efficacy, and behavior change. The results
suggest that RPM, as a component of a tradi-
tional DM program, has beneficial effects on par-
ticipants’ lifestyles after the monitoring period
has ended: by teaching individuals to associate
their behaviors with their resulting health status,
sustainable behavior change can be produced.
Thus, this research provides evidence support-
ing the value of designing and implementing
RPM programs that are efficient and tailored to
participants’ needs.
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